These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3836659)

  • 21. Multimodality treatment in anaplastic giant cell thyroid carcinoma.
    Tallroth E; Wallin G; Lundell G; Löwhagen T; Einhorn J
    Cancer; 1987 Oct; 60(7):1428-31. PubMed ID: 2441842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma.
    Auersperg M; Us-Krasovec M; Petric G; Pogacnik A; Besic N
    Wien Klin Wochenschr; 1990 Apr; 102(9):267-70. PubMed ID: 2375116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies.
    Green LD; Mack L; Pasieka JL
    J Surg Oncol; 2006 Dec; 94(8):725-36. PubMed ID: 17131397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma.
    Pierie JP; Muzikansky A; Gaz RD; Faquin WC; Ott MJ
    Ann Surg Oncol; 2002; 9(1):57-64. PubMed ID: 11833496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical options in undifferentiated thyroid carcinoma.
    Lang BH; Lo CY
    World J Surg; 2007 May; 31(5):969-77. PubMed ID: 17483987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases.
    Nel CJ; van Heerden JA; Goellner JR; Gharib H; McConahey WM; Taylor WF; Grant CS
    Mayo Clin Proc; 1985 Jan; 60(1):51-8. PubMed ID: 3965822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma.
    Higashiyama T; Ito Y; Hirokawa M; Fukushima M; Uruno T; Miya A; Matsuzuka F; Miyauchi A
    Thyroid; 2010 Jan; 20(1):7-14. PubMed ID: 20025538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The combined treatment of anaplastic thyroid carcinoma].
    Serrano M; Monroy C; Rodríguez-García JL; País JR; Fernández-Garrido M
    An Med Interna; 1994 Jun; 11(6):288-90. PubMed ID: 7918941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
    Pacheco-Ojeda LA; Martínez AL; Alvarez M
    Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.
    Tanaka K; Sugitani I; Fujimoto Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1074-8. PubMed ID: 21791572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
    Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
    Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic strategy for anaplastic carcinoma and malignant lymphoma of the thyroid].
    Taguchi T; Shiba E; Izukura M; Kimoto Y; Tanji Y; Takai S
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1593-9. PubMed ID: 8060133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
    Foote RL; Molina JR; Kasperbauer JL; Lloyd RV; McIver B; Morris JC; Grant CS; Thompson GB; Richards ML; Hay ID; Smallridge RC; Bible KC
    Thyroid; 2011 Jan; 21(1):25-30. PubMed ID: 21162687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.
    O'Neill JP; O'Neill B; Condron C; Walsh M; Bouchier-Hayes D
    J Laryngol Otol; 2005 Aug; 119(8):585-91. PubMed ID: 16102210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiated thyroid carcinoma.
    Hershman JM; Gordon HE
    Curr Ther Endocrinol Metab; 1997; 6():122-6. PubMed ID: 9174719
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spindle and giant cell carcinoma of the thyroid: a different therapeutic approach.
    Rogers JD; Lindberg RD; Hill CS; Gehan E
    Cancer; 1974 Oct; 34(4):1328-32. PubMed ID: 4418930
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer.
    Spires JR; Schwartz MR; Miller RH
    Arch Otolaryngol Head Neck Surg; 1988 Jan; 114(1):40-4. PubMed ID: 3334817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.